Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia--feasibility and safety study (Q44552933)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 March 2008

Language	Label	Description	Also known as
English	Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia--feasibility and safety study	scientific article published on 18 March 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia--feasibility and safety study (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Xiao-Jun Huang

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Yu Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Dai-Hong Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Lan-Ping Xu

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Huan Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Yu-Hong Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Wei Han

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Hong-Xia Shi

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Kai-Yan Liu

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

18 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Journal of Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

390-397

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Chemotherapy and donor peripheral blood progenitor cells for acute leukemia in early relapse after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic infusion of donor granulocyte colony stimulating factor mobilized peripheral blood progenitor cells after allogeneic hematological stem cell transplantation in patients with high-risk leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stage-specific application of allogeneic and autologous marrow transplantation in the management of acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The search for optimal treatment in relapsed and refractory acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation and application of the AmpF/STR profiler plus PCR amplification kit in a Bavarian population sample

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome after allogeneic bone marrow transplant for leukemia in older adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An improved anti-leukemic effect achieved with donor progenitor cell infusion for relapse patients after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18347959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10875-008-9193-4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44552933&oldid=2206736080"